3522集团新网站

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer via Bcl-2

Huan Wang, Wenqin Luo, Xuliang Wang, Dingwei Xue, Liangliang Ren, Li Xu, Guangju Ge, Liqun Xia, Shicheng Yu, Mingchao Wang, Zhenwei Zhou, Gonghui Li, Haiyang Wu

Journal:Frontiers in Molecular Biosciences

IF:5.25

DOI:10.3389/fmolb.2021.670409

PMID:34616769

Published:2021-09-20

research field:微生物组研究细胞生物学免疫学再生医学代谢学

Abstract

Testicular nuclear receptor 4 (TR4) is a member of the nuclear hormone receptor family and acts as a ligand-activated transcription factor and functions in many biological processes, such as development, cellular differentiation, and homeostasis. Recent studies have shown that TR4 plays an important role in prostate cancer, renal cell carcinoma, and hepatocellular carcinoma; however, its potential link to bladder cancer (BC) remains unknown. This study found that bladder cancer exhibited a higher expression of TR4 compared to normal tissues. Overexpressed TR4 promoted the bladder cancer cell proliferation, and knocked down TR4 with TR4-siRNA suppressed the bladder cancer cell proliferation. Mechanistic studies reveal that TR4 functions by altering the expression of Bcl-2 to regulate apoptosis in bladder cancer cells. Furthermore, knocking down Bcl-2 reversed the BC proliferation induced by TR4. In vivo , we also confirmed that TR4 knockdown mice (TR4 +/- ) showed slower bladder cancer growth than wild-type mice (TR4 +/+ ) induced by the carcinogenic chemicals. Moreover, TR4 +/- mice showed a lower grade of histopathology than the control group. In conclusion, these results indicate that TR4 plays a key role in bladder cancer proliferation, and targeting TR4 would probably be a potential strategy for bladder cancer treatment.

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用